Skip to main content Skip to main navigation menu Skip to site footer
Reumatismo

Editor-in-Chief: M.A. Cimmino, Genova, Italy | eISSN 2240-2683

  • About the Journal
  • Publication Ethics
  • Editorial Board
  • Current Issue
  • Early Access
  • Archives
  • Special Issues
    • Overview
  • Register
  • Login
  • Search
  • Contacts
  • News
1.2
Impact Factor
2025
1.5
CiteScore
2025
This journal has not published any issues.
1.2
Impact Factor 2025
1.5
CiteScore 2025
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • Achievement of sustained deep remission with adalimumab in a patient with both refractory ulcerative colitis and seronegative erosive rheumatoid arthritis

    G. Andrisani, E. Gremese, L. Guidi, A. Papa, M. Marzo, C. Felice, D. Pugliese, A. Armuzzi
    75-78
    27-05-2013
    https://doi.org/10.4081/reumatismo.2013.75
    3230
    Downloads: 1083
  • Splenic tuberculosis in a patient with ankylosing spondylitis treated with adalimumab

    V.F. Azevedo, E. Paiva, T. Tosin, A. Ferreira, A.M. Ferreira, M. Fernandes
    171-174
    09-11-2011
    https://doi.org/10.4081/reumatismo.2011.171
    1278
    Downloads: 948
  • Predictive factors for partial remission according to the Ankylosing Spondylitis Assessment Study working group in patients with ankylosing spondylitis treated with anti-TNFα drugs

    F.M. Perrotta, O. Addimanda, R. Ramonda, S. D’Angelo, E. Lubrano, A. Marchesoni, I. Olivieri, L. Punzi, C. Salvarani, A. Spadaro
    208-214
    06-11-2014
    https://doi.org/10.4081/reumatismo.2014.756
    3077
    Downloads: 1717
  • Anti-TNF agents for the treatment of active non-radiographic axial spondyloarthritis

    I. Olivieri, Salvatore D'Angelo, C. Palazzi, P. Leccese, A. Nigro, A. Padula
    1-3
    28-03-2013
    https://doi.org/10.4081/reumatismo.2013.1
    2471
    Downloads: 881
  • Psoriatic arthritis: treatment strategies using biologic agents

    S. D'Angelo, C. Palazzi, I. Olivieri
    113-121
    05-06-2012
    https://doi.org/10.4081/reumatismo.2012.113
    1584
    Downloads: 1290
  • A comprehensive evaluation of the transition to a biosimilar of adalimumab in rheumatoid arthritis and psoriatic arthritis: a single-center experience with a focus on imaging outcomes

    Rodrigo Garcia-Salinas, Sebastian Magri, Alvaro Ruta, Santiago Ruta
    08-05-2025
    https://doi.org/10.4081/reumatismo.2025.1748
    1457
    Downloads: 530
  • Anti-tumor necrosis factor α: originators versus biosimilars, comparison in clinical response assessment in a multicenter cohort of patients with inflammatory arthropathies

    C. Gioia, A. Picchianti Diamanti, R. Perricone, M.S. Chimenti, A. Afeltra, L. Navarini, A. Migliore, U. Massafra, V. Bruzzese, P. Scolieri, C. Meschini, M. Paroli, R. Caccavale, P. Scapato, R. Scrivo, F. Conti, B. Laganà, M. Di Franco
    19-12-2023
    https://doi.org/10.4081/reumatismo.2023.1602
    2388
    Downloads: 592
  • A short history of anti-rheumatic therapy - VII. Biological agents

    G. Pasero, P. Marson, B. Gatto
    185-194
    09-11-2011
    https://doi.org/10.4081/reumatismo.2011.185
    1880
    Downloads: 1389
  • PO:02:024 | Development of anti-drug antibodies in patients with peripheral and/or axial spondyloarthritis treated with infliximab or adalimumab: a monocentric cross-sectional study Gabriele Amati1, Gilda Sandri1|2, Alessandra Melegari3, Benedetta Bongiovanni1|2, Giovanni Ciancio2, Martina Orlandi1|2, Ottavio Secchi1, Dilia Giuggioli1|2 | 1Struttura complessa di Reumatologia, Azienda Ospedaliero-Universitaria Policlinico di Modena; 2Cattedra di Reumatologia, Università degli studi di Modena e Reggio Emilia; 3Dipartimento di medicina di laboratorio, Ospedale di Baggiovara, AUSL di Modena, Italy

    Società Italiana di Reumatologia
    25-11-2025
    https://doi.org/10.4081/reumatismo.2025.2126
    272
  • GISEA: an Italian biological agents registry in rheumatology

    G. Lapadula, G. Ferraccioli, C. Ferri, L. Punzi, F. Trotta
    155-164
    09-11-2011
    https://doi.org/10.4081/reumatismo.2011.155
    2977
    Downloads: 1793
  • Biologic therapy with anti-TNFa in spondyloarthritides and other autoimmune diseases

    G. Lapadula
    22-29
    https://doi.org/10.4081/reumatismo.2005.4s.22
    1000
    Downloads: 1217
  • Inflammatory back pain as an unusual manifestation of Takayasu arteritis: a case report

    Faiq Gorial, Nabaa Awadh, Ali Al-Shakarchi, Ghaith Al-Gburi
    30-10-2024
    https://doi.org/10.4081/reumatismo.2024.1678
    2444
    Downloads: 890
  • Efficacy and safety of anti-TNF agents in the Lombardy rheumatoid arthritis network (LORHEN)

    P. Sarzi- Puttini, M. Antivalle, A. Marchesoni, E.G. Favalli, R. Gorla, M. Filippini, R. Caporali, F. Bobbio-Pallavicini, C. Montecucco, F. Atzeni
    290-295
    https://doi.org/10.4081/reumatismo.2008.290
    2375
    Downloads: 1235
  • PO:02:018 | After-SECs: clinical predictors of secukinumab retention in psoriatic arthritis patients with inadequate response to anti-tumor necrosis factor therapy Francesco Cristiano1, Davide Gaspare Patti1, Valentina Boni1, Stefano Di Murro1, Cesare Gavotti1, Roberta Masnata1, Giulia Calabrese2, Gerlando Natalello2, Giusy Peluso2, Augusta Ortolan1|2, Enrico De Lorenzis1|2, Maria Antonietta D'Agostino1|2. | 1Università Cattolica del Sacro Cuore, Roma, Italy; 2Divisione di Reumatologia ed Immunologia clinica, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy.

    Società Italiana di Reumatologia
    25-11-2025
    https://doi.org/10.4081/reumatismo.2025.2009
    250
  • Biologic therapy with anti-TNFa in rheumathoid atrhritis

    G. Ferraccioli
    17-21
    https://doi.org/10.4081/reumatismo.2005.4s.17
    922
    Downloads: 783
  • Neprhrotic syndrome in a patient with rheumatoid arthritis treated with adalimumab: a case report

    M.G. Portuesi, P. Perosa
    61-63
    https://doi.org/10.4081/reumatismo.2008.61
    1371
    Downloads: 1001
  • PO:10:154 | Pudendal nevralgia as an unusual presenting symptom of axial spondyloarthritis Benedetta Bongiovanni1, Gabriele Amati1, Gilda Sandri1|2, Giovanni Ciancio2, Dilia Giuggioli1|2 | 1Struttura complessa di Reumatologia, azienda ospedaliera universitaria Policlinico di Modena; 2Cattedra di Reumatologia, università degli studi di Modena e Reggio Emilia, Modena, Italy

    Società Italiana di Reumatologia
    25-11-2025
    https://doi.org/10.4081/reumatismo.2025.2148
    350
  • Differences in pharmacology of tumor necrosis factor (TNF) antagonists

    U. Fiocco, S. Bombardieri
    8-16
    https://doi.org/10.4081/reumatismo.2005.4s.8
    1428
    Downloads: 1900
  • Herpes zoster seven days after SARS-CoV-2 vaccination in a patient with ankylosing spondylitis under adalimumab

    J. Finsterer
    03-05-2022
    https://doi.org/10.4081/reumatismo.2022.1474
    2259
    Downloads: 721
  • Leishmaniasis in rheumatoid arthritis

    C. Pizzorni, M.E. Secchi, M. Cutolo
    235-239
    https://doi.org/10.4081/reumatismo.2007.235
    1762
    Downloads: 1154
  • PO:05:066 | Atypical diagnosis and manifestation of spondyloarthritis: a case report Adele Del Giudice1, Filippo Crescentini2, Giorgia Citriniti2, Luca Cimino1|3, Carlo Salvarani1|2 | 1Department of Rheumatology, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy; 2Department of Medicine, University of Melbourne at St Vincent's Hospital Melbourne, Australia; 3Department of Rheumatology, Division of Medicine, University College, London, UK

    Società Italiana di Reumatologia
    25-11-2025
    https://doi.org/10.4081/reumatismo.2025.2132
    229
  • Effects of TNF antagonists on immune and neuroendocrine system

    G. Valesini, M. Cutolo
    3-7
    https://doi.org/10.4081/reumatismo.2005.4s.3
    1632
    Downloads: 908
  • COVID-19 pandemic and biological therapy in rheumatologic disorders: how to deal with?

    Z. Ahmadinejad, R. Assari, N. Ayoobi Yazdi, S.-H. Mazloomi, P. Javanshayani, H. Khalili Afousi, V. Ziaee
    173-177
    19-11-2020
    https://doi.org/10.4081/reumatismo.2020.1289
    2137
    Downloads: 1217
  • A comparison between the Simplified Disease Activity Index (SDAI) and the Disease Activity Score (DAS28) as measure of response to treatment in patients undergoing different therapeutic regimens

    Giovanna Cuomo, Gabriella Molinaro, Giovanni La Montagna, Sergio Migliaresi, Gabriele Valentini
    22-25
    https://doi.org/10.4081/reumatismo.2006.22
    1780
    Downloads: 2139
  • Infections in patients with rheumatoid arthritis receiving anti-cytokine therapy: biological mechanisms and clinical aspects

    C. Botsios, P. Ostuni, P. Sfriso, A. Furlan, U. Fiocco, D. Sgarabotto, S. Todesco
    224-235
    https://doi.org/10.4081/reumatismo.2003.224
    1370
    Downloads: 2874
  • Safety of anti-TNFa biological drugs

    F. Trotta, G. Valentini
    34-39
    https://doi.org/10.4081/reumatismo.2005.4s.34
    1438
    Downloads: 1588
  • PO:03:034 | Inhibition of Radiographic Progression with Bimekizumab Treatment Observed in bDMARD-Naïve Patients with Active Psoriatic Arthritis at 2 Years: Results from a Phase 3 Study and its Open-Label Extension Laura C Coates1, M Elaine Husni2, Mitsumasa Kishimoto3, Proton Rahman4, Philipp Sewerin5, Enrique R Soriano6, Barbara Ink7, Rajan Bajracharya7, Jason Coarse8, Philip J Mease9, Emanuela Mazzola10, Peter Nash11 | 1NDORMS, University of Oxford and Oxford Biomedical Research Centre, Oxford University Hospitals NHS Trust Oxford, United Kingdom; 2Department of Rheumatic and Immunologic Diseases, Cleveland Clinic Cleveland, USA; 3Department of Nephrology and Rheumatology, Kyorin University School of Medicine Tokyo, Japan; 4Division of Rheumatology, Craig L. Dobbin Genetics Research Centre, Memorial University of Newfoundland St. Johns, Canada; 5Rheumazentrum Ruhrgebiet, University Hospital of the Ruhr University Bochum Herne Germany; 6Hospital Italiano de Buenos Aires and University Institute Hospital Italiano de Buenos Aires Buenos Aires, Argentina; 7UCB Slough, United Kingdom; 8UCB Morrisville, USA; 9Department of Rheumatology, Providence-Swedish Medical Center and University of Washington Seattle, USA; 10UCB Milan, Italy; 11School of Medicine, Griffith University, Brisbane, Australia

    Società Italiana di Reumatologia
    18-03-2026
    https://doi.org/10.4081/reumatismo.2025.2290
    159
  • Acute toxoplasmosis infection in a patient with ankylosing spondylitis treated with adalimumab: a case report

    V.F. Azevedo, C.F. Pietrovski, M. de Almeida Santos Jr
    283-285
    https://doi.org/10.4081/reumatismo.2010.283
    1634
    Downloads: 1447
  • Approved indications and other possible utilizations of anti-TNFa biologic drugs

    W. Grassi, C. Montecucco
    30-33
    https://doi.org/10.4081/reumatismo.2005.4s.30
    1426
    Downloads: 966
  • Switching between TNFα antagonists in rheumatoid arthritis: personal experience and review of the literature

    R. Scrivo, F. Conti, F.R. Spinelli, S. Truglia, L. Magrini, M. Di Franco, F. Ceccarelli, G. Valesini
    107-117
    https://doi.org/10.4081/reumatismo.2009.107
    2154
    Downloads: 1330
1 - 30 of 30 items
Make a Submission

authors

FOR AUTHORS
  • ARTICLE PROCESSING CHARGE
  • Guide for Authors
  • Benefits for Authors
  • How to write a scientific paper
  • How to write a Review article

reviewers

FOR REVIEWERS
  • Benefits for Reviewers
  • How to review
  • Thanks to Reviewers

Categories

    • Abstract Book
    • Oral Communications - Day 1
    • Posters - Day 1
    • Oral Communications - Day 2
    • Posters - Day 2
    • Oral Communications - Day 3

indexing

INDEXING
  • PubMed
  • Scopus
  • Web of Science
  • Google Scholar
  • OpenAlex
  • Scilit
  • DOAJ
  • Società Italiana di Reumatologia
  • Analytics

social

Follow Reumatismo on

Keywords

Reumatismo

is the Official Journal of the Italian Society of Rheumatology (SIR). Founded in 1949. Published online by PAGEPress®, Pavia, Italy. All credits and honors to PKP for their OJS.

pISSN: 0048-7449
eISSN: 2240-2683

Info

  • About
  • Editorial Board
  • News
  • Advertising

Submissions

  • Submission
  • Guidelines For Authors

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185
This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.